FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

830160007: Crizanlizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3880787013 Crizanlizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3880788015 Crizanlizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Crizanlizumab Has disposition Selective adhesion molecule inhibitor true Inferred relationship Existential restriction modifier
Crizanlizumab Is a Substance with selective adhesion molecule inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Crizanlizumab Is a Monoclonal immunoglobulin G true Inferred relationship Existential restriction modifier
Crizanlizumab Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Crizanlizumab Is a Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Crizanlizumab Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Crizanlizumab Has active ingredient True Crizanlizumab Inferred relationship Existential restriction modifier 1
Product containing only crizanlizumab in parenteral dose form (medicinal product form) Has active ingredient True Crizanlizumab Inferred relationship Existential restriction modifier 1
Product containing crizanlizumab in parenteral dose form (medicinal product form) Has active ingredient True Crizanlizumab Inferred relationship Existential restriction modifier 1
Product containing crizanlizumab (medicinal product) Has active ingredient True Crizanlizumab Inferred relationship Existential restriction modifier 1
Crizanlizumab 100mg/10ml solution for infusion vials Has specific active ingredient True Crizanlizumab Inferred relationship Existential restriction modifier
Adakveo 100mg/10ml concentrate for solution for infusion vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Crizanlizumab Inferred relationship Existential restriction modifier
Crizanlizumab 100mg/10ml solution for infusion vials 1 vial Has specific active ingredient True Crizanlizumab Inferred relationship Existential restriction modifier
Adakveo 100mg/10ml concentrate for solution for infusion vials (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Crizanlizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start